Ambrx since Dec 2003
Director, Product Development and Characterization
Education:
University of California, San Diego 1986 - 1992
Ph.D., Biochemistry
Skills:
Protein Chemistry Protein Purification Biotechnology Purification Biochemistry Analytical Chemistry Technology Transfer Molecular Biology Formulation R&D Recombinant Dna Technology Clinical Development Process Simulation Science
Us Patents
Methods For Expression And Purification Of Pegylated Recombinant Human Growth Hormone Containing A Non-Naturally Encoded Keto Amino Acid
Ying Buechler - Carlsbad CA, US Ricky Lieu - San Diego CA, US Michael Ong - San Diego CA, US Stuart Bussell - Carlsbad CA, US Nick Knudsen - San Diego CA, US Ho Sung Cho - San Diego CA, US
Assignee:
AMBRX, Inc. - La Jolla CA
International Classification:
C12N 15/09 A61K 38/27 C07K 14/00
US Classification:
435 694, 424123, 424124, 514 114, 530399, 530416
Abstract:
The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
Methods For Expression And Purification Of Recombinant Human Growth Hormone Mutants
Ying Buechler - Carlsbad CA, US Ricky Lieu - San Diego CA, US Michael Ong - San Diego CA, US Stuart Bussell - Carlsbad CA, US Nick Knudsen - San Diego CA, US Ho Sung Cho - San Diego CA, US
The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
Process Of Producing Non-Naturally Encoded Amino Acid Containing High Conjugated To A Water Soluble Polymer
Ying Buechler - Carlsbad CA, US Ricky Lieu - San Diego CA, US Michael Ong - San Diego CA, US Stuart Bussell - Carlsbad CA, US Nick Knudsen - San Diego CA, US Ho Sung Cho - San Diego CA, US
Assignee:
AMBRX, Inc. - La Jolla CA
International Classification:
C12N 15/09 A61K 38/27 C07K 14/00
US Classification:
435 694, 435123, 514 114, 530399, 530416
Abstract:
The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
Formulations Of Human Growth Hormone Comprising A Non-Naturally Encoded Amino Acid
Ying Buechler - Carlsbad CA, US Ricky Lieu - San Diego CA, US Michael Ong - San Diego CA, US Stuart Bussell - Carlsbad CA, US Nick Knudsen - San Diego CA, US Ho Sung Cho - San Diego CA, US
The present invention relates generally to the production, purification, and isolation of human growth hormone (hGH). More particularly, the invention relates to the production, purification, and isolation of substantially purified hGH comprising non-naturally encoded amino acids and hGH from recombinant host cells or culture medium including, for example, yeast, insect, mammalian and bacterial host cells. The process of the present invention is also useful for purification of hGH linked to polymers or other molecules.
Modified Human Growth Hormone Formulations With An Increased Serum Half-Life
Anna-Maria Hays - La Jolla CA, US Ying Buechler - Carlsbad CA, US David C. Litzinger - Poway CA, US
Assignee:
AMBRX, Inc. - La Jolla CA
International Classification:
A61K 38/27 A61K 39/00 C07K 14/61 C07K 14/00
US Classification:
514 114, 530399, 530402, 4241981
Abstract:
Formulations of modified growth hormone polypeptides are provided, including human growth hormone polypeptides with one or more non-naturally encoded amino acids with an increased half-life.
Chun Shen - San Diego CA, US Ying Buechler - Carlsbad CA, US Xiaochun Chen - Carlsbad CA, US Dawn Wen - San Diego CA, US Yixin Wang - Shenzhen, CN Shehui He - Shenzhen, CN Qianlan Wang - Shenzhen, CN
International Classification:
A61K 38/21 C07K 14/56
US Classification:
424085700, 530351000
Abstract:
The invention provides PEG-IFN α-1b conjugates, where a PEG moiety is covalently bound to Cysof human IFN α-1b conjugates. A pharmaceutical composition and a method for treating inflammatory diseases, infections, and cancer are also provided. The invention further relates to a method for the modification of interferons by conjugation of a PEG moiety to free cysteine residues in interferon molecules.
Formulations Of Human Growth Hormone Comprising A Non-Naturally Encoded Amino Acid